FST产品代理

产品分类 > 科研试剂 > FST产品代理

FST产品代理

杭州飞思特制药 有限公司成立于2001年9月,公司原位于建德市梅城城南工业区,是国家高新技术企业。主要从事化学合成天然药物系列、抗肿瘤替尼系列、心血管系列、抗组胺系列、抗精神病药、兽药等活性物质及医药中间体的研发与生产。我们的产品主要销往韩国、中东、欧美等国家和地区,并与国内外多家知名制药企业建立了长期的合作关系,享有较高的知名度并在业界享有良好的声誉。
公司现有职工240余人,其中大专以上学历科技人员99人,占企业职工总数的41%,直接从事研发工作的37人,占15%占企业职工总数的比例。公司拥有省级企业研究院,拥有自主知识产权13项,其中发明专利9项,实用新型专利4项。
2015年12月,公司加入人福集团(股票代码600079),成为集团控股子公司。 2019年5月,公司响应政府号召,搬迁至高铁新区五马洲区块。新厂区投资3600万美元,占地面积12亩,建筑面积39732平方米。拥有4个高标准多层立体多功能车间,严格按照新GMP标准设计建造。全部采用DCS自动控制管理。公司已通过ISO9001质量管理体系、ISO14001环境管理体系、GB/T28001职业安全健康管理体系认证,拥有较为完善的GMP/FDA标准质量保证体系。部分产品通过了美国FDA现场审核和DMF/COS认证。
价格: 0.00

Hangzhou FST pharmaceutical Co., Ltd. was established in September, 2001. Our company was originally located in Jiande City Meicheng Chengnan Industrial Zone, is a national high-tech enterprise. It is mainly engaged in the research and development and production of chemical synthetic natural drug series, antitumor tinib series, cardiovascular series, antihistamine series, antipsychotics, veterinary drugs and other active substances and pharmaceutical intermediates. 

Our products   are mainly sold to South Korea, the Middle East, Europe and the United States   and other countries and regions, and with many well-known pharmaceutical   enterprises at home and abroad to establish a long-term relationship of   cooperation, enjoying a higher visibility and good reputation in the   industry.

Our company   has more than 240 employees, among which 99 are scientific and technical   personnel with college degree or above, accounting for 41% of the total   number of employees of the enterprise, and 37 are directly engaged in   research and development, accounting for 15% of the total number of employees   of the enterprise.Our company has a provincial enterprise research institute   and owns 13 independent intellectual property rights, including 9 invention   patents and 4 utility model patents.

   

In December 2015, the company joined Humanwell Group (stock code 600079) and became a holding subsidiary of the group. In May 2019, the company responded to the call of the government and moved to the Wumazhou Block of the High-speed Railway New Area. The new factory has an investment of 36 million USD,covers an area of 12 acre, and a construction area of 39,732 square meters. It has 4 high-standard multi-layer three-dimensional multi-functional workshops, which are designed and built in strict accordance with the new GMP standard. All of them adopt DCS automatic

control and management. The company has passed ISO9001 quality management system, ISO14001 environmental management system, GB/T28001 occupational safety and health management system certification, has a more complete GMP/FDA standard quality assurance system. Some products have passed the US FDA on-site audit and DMF/COS certification.